Czibere Akos — SEC insider filings

SEC reporting owner CIK 2049427. 2 insider filings on record with FilingPulse; latest filed 2026-09-24.

Transaction summary — filings shown

Covers all 2 filings on record, filed 2026-07-10 to 2026-09-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Aktis Oncology, Inc. (AKTS)Chief Medical Officer2—5 legs · 62,500 sh · $1,647,3224

Insider filings — Czibere Akos

FiledFormIssuerReported transactionsSource
2026-09-244Aktis Oncology, Inc. (AKTS)Option exercise (M): 12,500 @ $4.95 · Sale (S): 5,099 @ $20.19 · Sale (S): 7,401 @ $21.03 · Option exercise (M): 12,500 (derivative) @ $0EDGAR
2026-07-104Aktis Oncology, Inc. (AKTS)Option exercise (M): 50,000 @ $4.95 · Sale (S): 14,800 @ $27.13 · Sale (S): 30,829 @ $27.95 · Sale (S): 4,371 @ $28.71 · Option exercise (M): 50,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2022-05-23 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2049427 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs